Alnylam Pharmaceuticals | ALNY - 贸易债权人

股票价格

311.10

每天变化

-3.70 -1.18%

每月一次

-7.46%

每年

22.70%

Q1 预测

303.95

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 40.65B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	贸易债权人	更改		日
Acadia Pharmaceuticals	USD 10.9M		10.84M	2025-12
Agios Pharmaceuticals	USD 18.36M		1.2M	2025-12
Alnylam Pharmaceuticals	USD 115.72M		1.87M	2025-12
Amgen	USD 20.89B		1.25B	2025-12
Arrowhead Research	USD 32.94M		15.26M	2025-12
BioCryst Pharmaceuticals	USD 15.83M		10.26M	2025-12
BioMarin Pharmaceutical	USD 759.03M		39.41M	2025-12
Incyte	USD 1.63B		1.46B	2025-12
Ionis Pharmaceuticals	USD 14.33M		8.47M	2025-09
Moderna	USD 317M		50M	2025-12
Neurocrine Biosciences	USD 545.5M		425.6M	2025-12
Novartis	USD 4.46B		99M	2025-12
PTC Therapeutics	USD 45.49M		8.87M	2025-12
Regeneron Pharmaceuticals	USD 5.83B		4.93B	2025-12
Sangamo BioSciences	USD 10.74M		7.46M	2025-06
Sanofi	EUR 22.93B		2.89B	2025-12
Sarepta Therapeutics	USD 280.84M		186.83M	2025-12
Takeda	JPY 467.59B		28.61B	2025-12
Tectonic Therapeutic	USD 1.09M		392K	2025-12
Ultragenyx Pharmaceutical	USD 40.57M		6.33M	2025-09
Vertex Pharmaceuticals	USD 3.43B		600.9M	2025-12
Xencor	USD 10.83M		1.75M	2025-12